{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:53:33Z","timestamp":1771674813387,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background\/Purpose<\/jats:title><jats:p>Alopecia areata (<jats:styled-content style=\"fixed-case\">AA<\/jats:styled-content>) is a common cause of localized non\u2010scarring alopecia. Usage of targeted <jats:styled-content style=\"fixed-case\">UVA<\/jats:styled-content> after the topical application of 8\u2010methoxypsoralen (8\u2010<jats:styled-content style=\"fixed-case\">MOP<\/jats:styled-content>) is one of the rising treatment modalities for <jats:styled-content style=\"fixed-case\">AA<\/jats:styled-content>. Our aim was to assess the efficacy and safety of topical 8\u2010<jats:styled-content style=\"fixed-case\">MOP<\/jats:styled-content> plus targeted <jats:styled-content style=\"fixed-case\">UVA<\/jats:styled-content> phototherapy in the treatment of patchy <jats:styled-content style=\"fixed-case\">AA<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seven patchy <jats:styled-content style=\"fixed-case\">AA<\/jats:styled-content> patients were treated by topical 8\u2010<jats:styled-content style=\"fixed-case\">MOP<\/jats:styled-content> application to the lesions followed by <jats:styled-content style=\"fixed-case\">UVA<\/jats:styled-content> irradiation 3 times a week, with 15 to 24 sessions in total. At the end of the treatment all patients were evaluated for response on a four\u2010point scale (0\u2009=\u2009no hair, 1\u2009=\u2009white vellus hair, 2\u2009=\u2009regrowth cosmetically acceptable for the patient, 3\u2009=\u2009complete hair growth).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean cumulative <jats:styled-content style=\"fixed-case\">UVA<\/jats:styled-content> dose was from 7.5 to 39.6\u2009J\/cm<jats:sup>2<\/jats:sup>. For all 7 patients, average response score was calculated as 2, which means cosmetically acceptable regrowth.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Targeted <jats:styled-content style=\"fixed-case\">UVA<\/jats:styled-content> phototherapy combined with topical 8\u2010<jats:styled-content style=\"fixed-case\">MOP<\/jats:styled-content> may be an effective and safe alternative treatment protocol for patchy <jats:styled-content style=\"fixed-case\">AA<\/jats:styled-content>, which should be kept in mind in order to choose the best for the patient, especially for patients incompatible with other treatments that are systemic and invasive.<\/jats:p><\/jats:sec>","DOI":"10.1111\/phpp.12073","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T15:29:11Z","timestamp":1381246151000},"page":"318-322","source":"Crossref","is-referenced-by-count":4,"title":["Targeted photochemotherapy in alopecia areata"],"prefix":"10.1111","volume":"29","author":[{"given":"G\u00fcrol","family":"A\u00e7\u0131kg\u00f6z","sequence":"first","affiliation":[{"name":"Department of Dermatology G\u00fclhane School of Medicine  Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Ye\u015fil","sequence":"additional","affiliation":[{"name":"Department of Dermatology G\u00fclhane School of Medicine  Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercan","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[{"name":"Department of Dermatology G\u00fclhane School of Medicine  Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Tunca","sequence":"additional","affiliation":[{"name":"Department of Dermatology G\u00fclhane School of Medicine  Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Akar","sequence":"additional","affiliation":[{"name":"Department of Dermatology G\u00fclhane School of Medicine  Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.4065\/70.7.628"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70392-2"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12375477"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1555"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05535.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.031"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02328.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2011.00566.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004413.pub2"},{"key":"e_1_2_6_11_1","first-page":"674","article-title":"Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs","volume":"71","author":"Kubeyinje EP","year":"1994","journal-title":"East Afr Med J"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70048-9"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2008.12.002"},{"key":"e_1_2_6_14_1","first-page":"141","article-title":"Treatment of alopecia areata with three different PUVA modalities","volume":"1","author":"Lassus A","year":"1984","journal-title":"Photodermatol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb06925.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.48655"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70032-D"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70009-X"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.10.980"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.09.010"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1987.01660350091020"},{"key":"e_1_2_6_22_1","first-page":"431","article-title":"3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata","volume":"41","author":"Fransway AF","year":"1998","journal-title":"Cutis"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fphpp.12073","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/phpp.12073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T23:15:28Z","timestamp":1696202128000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/phpp.12073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1111\/phpp.12073"],"URL":"https:\/\/doi.org\/10.1111\/phpp.12073","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]}}}